Comparison of Two Different Alveolar Ridge Preservation Techniques

February 6, 2017 updated by: Brandon Coleman, Eisenhower Army Medical Center
The purpose of this study is to compare two barrier membrane products, Cytoplast (dPTFE) and BioXclude (human amnion chorion allograft), for their relative efficacies in dental socket preservation procedures, both when the socket is filled and overfilled with freeze dried bone allograft (FDBA).

Study Overview

Detailed Description

This single-blind, randomized clinical trial aims to compare two different, commercially available materials to assess their relative efficacies in socket preservation procedures after tooth extraction. Patients presenting with single teeth deemed clinically hopeless and treatment planned for removal in the normal course of clinical dentistry will be considered for this study. If eligible, a ridge/socket preservation procedure will be performed at the time of extraction. Periodontics residents will perform the procedure under the supervision of board certified staff. Patients will be randomized via concealed random number sequence into one of four groups, based on a combination of materials and graft placement techniques. Patients will be equally distributed into the following groups: (1) dense polytetrafluoroethylene (Cytoplast) (2) Cytoplast with additional buccal augmentation/onlay graft, (3) human amniotic-tissue derived membrane (BioXclude), and (4) BioXclude with additional buccal augmentation/onlay graft. All four treatment groups are consistent with the current standard of care, and this study seeks to compare techniques and materials as part of routine, clinical/periodontal therapy in order to determine superiority. Approximately 150 patients will be enrolled and distributed equally among the four groups. Any post-operative complications will be managed and documented during follow-up appointments at 1, 2 and 4 weeks. Cone beam computed tomography (CBCT) will be used as the primary assessment tool, and scans will be compared between a pre-operative baseline time point and a scan taken after 4 months of healing to prepare for implant placement. The primary dependent variables will be (1) percent of baseline alveolar ridge changes (both horizontal and vertical) and (2) whether or not the anticipated dental implant could be placed appropriately. Secondary outcomes include ease of use, perceptions of pain, complications, cost-effectiveness, and changes in keratinized tissue.

Study Type

Interventional

Enrollment (Anticipated)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Georgia
      • Fort Gordon, Georgia, United States, 30905
        • Tingay Dental Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All active duty military patients (age 18-65) referred to the investigators' facility's periodontics department for diagnosis of "hopeless" tooth with documented confirmation of diagnosis by periodontal staff
  • Eligible for extraction and ridge preservation (adequately healthy and not otherwise disqualified)

Exclusion Criteria:

  • Pregnant or breastfeeding
  • History of allergy to involved products
  • Current acute infection at the site (chronic periapical infections will not exclude the patient)
  • Elian Type 3 extraction sockets
  • Sites not treatment planned for implant therapy
  • Third molar sites
  • American Society of Anesthesiology Category III patients (medically compromised)
  • Active duty military patients in a student status

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Cytoplast
Patients will receive ridge preservation procedure with a Cytoplast barrier membrane
ridge preservation intervention using the dPTFE membrane device
Other Names:
  • Cytoplast
ridge preservation intervention with additional freeze dried bone allograft (FDBA) placed buccal to the socket
ridge preservation without overlay graft / traditional FDBA placement into the socket only
EXPERIMENTAL: BioXclude
Patients will receive ridge preservation procedure with a BioXclude barrier membrane
ridge preservation intervention with additional freeze dried bone allograft (FDBA) placed buccal to the socket
ridge preservation without overlay graft / traditional FDBA placement into the socket only
ridge preservation intervention using the dPTFE membrane device
Other Names:
  • BioXclude

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Alveolar Ridge Width
Time Frame: from baseline to final cone beam CT scan (approximately 4 months)
Alveolar ridge dimensional change (horizontal) from Cone beam CT
from baseline to final cone beam CT scan (approximately 4 months)
Alveolar Ridge Height
Time Frame: from baseline to final cone beam CT scan (approximately 4 months)
Alveolar ridge dimensional change (vertical) from cone beam CT
from baseline to final cone beam CT scan (approximately 4 months)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post-operative pain perception
Time Frame: 1 week after surgical extraction procedure
self-report by patient on visual analog scale
1 week after surgical extraction procedure
Platform size of implant placed
Time Frame: Implant surgery, approximtely 4 months after baseline
Whether or not the originally intended implant size could be placed
Implant surgery, approximtely 4 months after baseline
Keratinized tissue width (baseline)
Time Frame: pre-op / baseline assessment (after randomization)(prior to time=0)
pre-op / baseline assessment (after randomization)(prior to time=0)
Keratinized tissue width (final)
Time Frame: from pre-op assessment at time of randomization to implant surgery (4 months)
from pre-op assessment at time of randomization to implant surgery (4 months)
Elian classification (anticipated)
Time Frame: pre-op / baseline assessment (after randomization)(prior to time=0)
Operators will report an anticipated socket preservation classification according to Elian 2007
pre-op / baseline assessment (after randomization)(prior to time=0)
Elian classification (actual)
Time Frame: intra-operative surgical finding (extraction surgery)(time=0)
Operators will report the actual socket preservation classification according to Elian 2007
intra-operative surgical finding (extraction surgery)(time=0)
Buccal plate thickness
Time Frame: intra-operative surgical finding (extraction surgery)(time = 0)
intra-operative measurements, presence or absence of a dehiscence / fenestration
intra-operative surgical finding (extraction surgery)(time = 0)
Buccal plate fenestration
Time Frame: intra-operative surgical finding (extraction surgery)(time = 0)
determined at time of extraction surgery, and noted as a possible confounding variable
intra-operative surgical finding (extraction surgery)(time = 0)
Complications after surgery (infection)
Time Frame: 0-4 months
infection, determined by presence of purulence, lymphadenopathy and/or febrile status
0-4 months
Complications after surgery (membrane exfoliation)
Time Frame: 0-4 months
dichotomous variable, presence or absence of the membrane for the duration of the study
0-4 months
Peri-operative clinician's report (extraction difficulty)
Time Frame: intra-operative surgical finding (extraction surgery)
subjective extraction difficulty, as reported by the clinician
intra-operative surgical finding (extraction surgery)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sedation utilization
Time Frame: intra-operative surgical variable (determined in advance, at baseline)
presence or absence of sedation drugs during the procedure
intra-operative surgical variable (determined in advance, at baseline)
Cost
Time Frame: 0-4 months
cost/benefit for each product
0-4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Brandon Coleman, DDS,MS, US Army Fort Gordon DENTAC

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2015

Primary Completion (ANTICIPATED)

July 1, 2018

Study Completion (ANTICIPATED)

July 1, 2018

Study Registration Dates

First Submitted

June 19, 2015

First Submitted That Met QC Criteria

June 25, 2015

First Posted (ESTIMATE)

June 26, 2015

Study Record Updates

Last Update Posted (ESTIMATE)

February 7, 2017

Last Update Submitted That Met QC Criteria

February 6, 2017

Last Verified

February 1, 2017

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Loss of Teeth Due to Extraction

Clinical Trials on dense polytetrafluoroethylene (dPTFE) membrane Cytoplast

3
Subscribe